DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Juhee Roh, Post Graduate Year 2 House Officer, Waitemata District Health Board, Auckland, New Zealand. Copy edited by Gus Mitchell. November 2020.
Paediatric alopecia areata is an autoimmune form of nonscarring hair loss defined as being in childhood if the onset is by 10 years of age, or adolescence if between 11 and 20 years.
Alopecia areata is common worldwide, affecting all races and both sexes. Approximately 2% of the general population will have alopecia areata at some point in their lives, and 60% of them will develop their first patch of hair loss before the age of 20 years. Prevalence peaks between 10 and 30 years of age. Large series have suggested paediatric-onset alopecia areata is more common in girls than boys, but is more severe in boys. Congenital alopecia areata has been reported.
Alopecia areata developing in the first ten years of life is strongly associated with atopic dermatitis (approximately one-third) and lupus erythematosus. In the teenage years, psoriasis and rheumatoid arthritis are also associated. Thyroid disease and other autoimmune conditions are not detected at increased incidence in children with alopecia areata, in contrast with adult-onset disease.
Alopecia areata is considered to be an organ-specific autoimmune condition of the hair follicle on a genetic background.
Alopecia areata often runs in families, and has been reported in monozygotic twins. Up to 25% of children will have at least one affected family member, and many have multiple relations with alopecia areata. It is reported to be common in Down syndrome and Turner syndrome — autoimmune disease is particularly common in Turner syndrome. This suggests a genetic predisposition to developing alopecia areata. However, investigations suggest the association is complex and polygenic.
Many hypotheses have been proposed attempting to explain the development of alopecia areata, but at this time the detailed pathogenesis is not understood.
Children typically present with a sudden onset of a solitary patch of hair loss, most commonly on the scalp, characterised by:
Alopecia areata can present with multiple patches on any hair-bearing body site, including eyebrows and eyelashes.
Patterns of alopecia areata include:
Alopecia areata patterns of hair loss in children
Nail changes were seen in almost 50% in one large series of children with alopecia areata, particularly pitting and trachyonychia (see Nail terminology). Nail changes do not correlate with the severity of the alopecia areata.
Nail changes in alopecia areata
Dermoscopy features of alopecia areata
Social and psychological effects are common with any form of hair loss in children and can have a serious impact on quality of life. Social isolation, humiliation by peers, low self-esteem, anxiety, stress, and depression are often associated with alopecia areata. Paediatric alopecia areata also has a significant impact on the family as a whole (see Psychological effects of hair loss).
Alopecia areata is usually a clinical diagnosis confirmed on dermoscopy. Wood light examination and examination of plucked hairs or skin scrapings may be required to exclude tinea capitis (see Laboratory tests for fungal infections). Skin biopsy is rarely required in children. Blood tests may be considered if there are concerns about coeliac disease or other associated autoimmune conditions.
The two most important differential diagnoses in children presenting with patchy nonscarring hair loss are:
No treatment changes the natural history of alopecia areata. ‘Wait and see’ is a reasonable option in young children with limited disease, as up to 50% show regrowth within one year. Treatment options for alopecia areata in children include:
A wig may be necessary for extensive hair loss. Referral to a psychologist should be considered when there is significant psychological distress.
Up to 50% of patients show regrowth within one year without treatment, but the course is unpredictable. Relapse is common even after apparently successful regrowth after treatment. Young age at first presentation is associated with a poor prognosis.
Other poor prognostic factors include:
Books about skin diseases
© 2020 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.